Low PIP4K2B expression in human breast tumors correlates with reduced patient survival: a role for PIP4K2B in the regulation of E-cadherin expression
Low PIP4K2B expression in human breast tumors correlates with reduced patient survival: a role for PIP4K2B in the regulation of E-cadherin expression
Phosphatidylinositol-5-phosphate (PtdIns5P) 4-kinase ? (PIP4K2B) directly regulates the levels of two important phosphoinositide second messengers, PtdIns5P and phosphatidylinositol-(4,5)-bisphosphate [PtdIns(4,5)P2]. PIP4K2B has been linked to the regulation of gene transcription, to TP53 and AKT activation, and to the regulation of cellular reactive oxygen accumulation. However, its role in human tumor development and on patient survival is not known. Here, we have interrogated the expression of PIP4K2B in a cohort (489) of patients with breast tumor using immunohistochemical staining and by a meta-analysis of gene expression profiles from 2,999 breast tumors, both with associated clinical outcome data. Low PIP4K2B expression was associated with increased tumor size, high Nottingham histological grade, Ki67 expression, and distant metastasis, whereas high PIP4K2B expression strongly associated with ERBB2 expression. Kaplan-Meier curves showed that both high and low PIP4K2B expression correlated with poorer patient survival compared with intermediate expression. In normal (MCF10A) and tumor (MCF7) breast epithelial cell lines, mimicking low PIP4K2B expression, using short hairpin RNA interference-mediated knockdown, led to a decrease in the transcription and expression of the tumor suppressor protein E-cadherin (CDH1). In MCF10A cells, knockdown of PIP4K2B enhanced TGF-?-induced epithelial to mesenchymal transition (EMT), a process required during the development of metastasis. Analysis of gene expression datasets confirmed the association between low PIP4K2B and low CDH1expression. Decreased CDH1 expression and enhancement of TGF-?-induced EMT by reduced PIP4K2B expression might, in part, explain the association between low PIP4K2B expression and poor patient survival.
6913-6925
Keune, Willem-Jan
b72d28ff-c2fa-4a86-bfa6-8452126ba844
Sims, Andrew H.
5a556bfd-40b9-4ed8-ad8b-96dfc99dcac7
Jones, David R
0004465a-9957-4573-aded-912302447fd9
Bultsma, Yvette
21f6f52e-dd7f-4018-8741-e756d8697d2a
Lynch, James T.
5d050669-1fdc-48c1-b1d0-62e881d9e355
Jirström, Karin
3af6df24-78b8-41c2-aa3f-3a34d0f15a3a
Landberg, Goran
67eb350e-8539-4c52-8d72-9bff37264d89
Divecha, Nullin
5c2ad0f8-4ce7-405f-8a15-2fc4ab96d787
1 December 2013
Keune, Willem-Jan
b72d28ff-c2fa-4a86-bfa6-8452126ba844
Sims, Andrew H.
5a556bfd-40b9-4ed8-ad8b-96dfc99dcac7
Jones, David R
0004465a-9957-4573-aded-912302447fd9
Bultsma, Yvette
21f6f52e-dd7f-4018-8741-e756d8697d2a
Lynch, James T.
5d050669-1fdc-48c1-b1d0-62e881d9e355
Jirström, Karin
3af6df24-78b8-41c2-aa3f-3a34d0f15a3a
Landberg, Goran
67eb350e-8539-4c52-8d72-9bff37264d89
Divecha, Nullin
5c2ad0f8-4ce7-405f-8a15-2fc4ab96d787
Keune, Willem-Jan, Sims, Andrew H., Jones, David R, Bultsma, Yvette, Lynch, James T., Jirström, Karin, Landberg, Goran and Divecha, Nullin
(2013)
Low PIP4K2B expression in human breast tumors correlates with reduced patient survival: a role for PIP4K2B in the regulation of E-cadherin expression.
Cancer Research, 73 (23), .
(doi:10.1158/0008-5472.CAN-13-0424).
(PMID:24127122)
Abstract
Phosphatidylinositol-5-phosphate (PtdIns5P) 4-kinase ? (PIP4K2B) directly regulates the levels of two important phosphoinositide second messengers, PtdIns5P and phosphatidylinositol-(4,5)-bisphosphate [PtdIns(4,5)P2]. PIP4K2B has been linked to the regulation of gene transcription, to TP53 and AKT activation, and to the regulation of cellular reactive oxygen accumulation. However, its role in human tumor development and on patient survival is not known. Here, we have interrogated the expression of PIP4K2B in a cohort (489) of patients with breast tumor using immunohistochemical staining and by a meta-analysis of gene expression profiles from 2,999 breast tumors, both with associated clinical outcome data. Low PIP4K2B expression was associated with increased tumor size, high Nottingham histological grade, Ki67 expression, and distant metastasis, whereas high PIP4K2B expression strongly associated with ERBB2 expression. Kaplan-Meier curves showed that both high and low PIP4K2B expression correlated with poorer patient survival compared with intermediate expression. In normal (MCF10A) and tumor (MCF7) breast epithelial cell lines, mimicking low PIP4K2B expression, using short hairpin RNA interference-mediated knockdown, led to a decrease in the transcription and expression of the tumor suppressor protein E-cadherin (CDH1). In MCF10A cells, knockdown of PIP4K2B enhanced TGF-?-induced epithelial to mesenchymal transition (EMT), a process required during the development of metastasis. Analysis of gene expression datasets confirmed the association between low PIP4K2B and low CDH1expression. Decreased CDH1 expression and enhancement of TGF-?-induced EMT by reduced PIP4K2B expression might, in part, explain the association between low PIP4K2B expression and poor patient survival.
This record has no associated files available for download.
More information
e-pub ahead of print date: 14 October 2013
Published date: 1 December 2013
Organisations:
Molecular and Cellular
Identifiers
Local EPrints ID: 372335
URI: http://eprints.soton.ac.uk/id/eprint/372335
ISSN: 0008-5472
PURE UUID: fc2228cd-6abd-4a72-8652-710c59178c59
Catalogue record
Date deposited: 10 Dec 2014 13:54
Last modified: 14 Mar 2024 18:35
Export record
Altmetrics
Contributors
Author:
Willem-Jan Keune
Author:
Andrew H. Sims
Author:
David R Jones
Author:
Yvette Bultsma
Author:
James T. Lynch
Author:
Karin Jirström
Author:
Goran Landberg
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics